Oxford Cancer is a city-wide network and partnership between Oxford University and Oxford University Hospitals NHS Trust based on the University’s Translational Biomedical Research Campus.
It harnesses Oxford’s world-leading cancer research from across disciplines, with the core aim of facilitating collaboration to ensure rapid translation from scientific discovery to treatments for patients.
Oxford Cancer currently comprises over 900 members from around 90 different Departments, Units, Institutes of the University, as well as the NHS Trust who invest over £55m each year into translational cancer research.
Oxford Cancer is an inclusive network of organisations in Oxford for whom cancer research is a priority focus. We support and connect people working across a range of disciplines and aim to facilitate research collaboration on a local, national and international scale to speed up translation from scientific discovery to treatments in patients.
Distinguishing between paediatric brain tumour types using multi-parametric magnetic resonance imaging and machine learning: A multi-site study.
23 January 2020
Grist et al. team trained computers to analyse brain images from children for identification of tumours. They’ve shown that applying analytical methods to enable machine distinguishes between...
Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma.
28 November 2019
Winter H, Kaisaki PJ, Harvey J, Giacopuzzi E, Ferla MP, Pentony MM, Knight SJL, Sharma RA, Taylor JC, McCullagh JSO. MDPI 2019, 11(12), 1895 Abstract Intrahepatic cholangiocarcinoma (ICC) is...